TCM

TCM EBIT CAGR 10Y

The EBIT CAGR (10 Year) of TCM (524156.BO) as of Nov 5, 2026 is 16.26 %. In the previous year, EBIT CAGR (10 Year) was 16.26 % — a change of 0.00% (lower).

EBIT CAGR 10Y

16.26 %

YoY

0.00%

Last updated:

EBIT CAGR (10 Year) of TCM is 2025 16.26 % . EBIT CAGR (10 Year) of TCM was 2024 16.26 % . It decreases by 0.00% lower compared to the previous year.

The TCM EBIT CAGR 10Y history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBIT CAGR 10Y
Date
EBIT CAGR 10Y
Jan 1, 2018
16.26 INR
Jan 1, 2019
16.26 INR
Jan 1, 2020
16.26 INR
Jan 1, 2021
16.26 INR
Jan 1, 2022
16.26 INR
Jan 1, 2023
16.26 INR
Jan 1, 2024
16.26 INR
Jan 1, 2025
16.26 INR
The TCM EBIT CAGR 10Y history
YEAREBIT CAGR 10YYoY
16.26 %0.00%
16.26 %0.00%
16.26 %0.00%
16.26 %0.00%
16.26 %0.00%
16.26 %0.00%
16.26 %0.00%
16.26 %0.00%
16.26 %0.00%
16.26 %0.00%
16.26 %0.00%
16.26 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

TCM Stock analysis

What does TCM do? TCM Ltd generates revenue through its Solar Division, which focuses on solar energy solutions, and the sale of auto care products and healthcare devices. The company's subsidiary TCM Healthcare Private Limited manufactures and trades SARS-CoV-2 test kits alongside a wide range of medical devices, including surgical, dental, and scientific equipment, as well as PPE kits, sanitizers, and disposable medical instruments. TCM Ltd's business segments target healthcare providers, automotive service centers, and renewable energy sectors, with products distributed through both direct sales and established distribution channels. The firm's healthcare segment includes the sale of medical devices, surgical instruments, and PPE kits, catering to hospitals, clinics, and healthcare facilities. Auto care products are sold to automotive dealerships and service centers, while solar solutions are marketed to energy companies and construction firms involved in renewable energy projects. TCM Healthcare Private Limited operates as a dedicated entity for medical product distribution, ensuring compliance with healthcare regulations and market demands. TCM Ltd's subsidiaries, iSpark Learning Solutions Pvt Ltd and TCM Healthcare Private Limited, support the company's diversified operations. iSpark Learning Solutions Pvt Ltd contributes to educational services, while TCM Healthcare Private Limited handles the medical device and test kit business, ensuring a seamless integration of healthcare product offerings within the company's broader portfolio. TCM is one of the most popular companies on Eulerpool.

Frequently Asked Questions about TCM stock

EBIT CAGR (10 Year) of TCM is 16.26 % in 2025.

On Eulerpool you can find the complete historical development of EBIT CAGR (10 Year) TCM since 2006 – with annual values, charts, and detailed analysis.

The 10-year EBIT CAGR shows the long-term compound annual growth rate of operating earnings.

To evaluate EBIT CAGR (10 Year)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for EBIT CAGR (10 Year).

EBIT CAGR (10 Year)'s is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track EBIT CAGR (10 Year)'s TCM historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Growth — TCM

All Key Metrics — TCM